Fumarate is an important probe of metabolism in hyperpolarized magnetic resonance imaging and spectroscopy. It is used to detect the release of fumarase in cancer tissues, which is associated with necrosis and drug treatment. Nevertheless, there are limited reports describing the detailed kinetic studies of this enzyme in various cells and tissues. Thus, we aimed to evaluate the sub-minute kinetics of human red blood cell fumarase using NMR spectroscopy, and provide a quantitative description of the enzyme that is relevant to the use of fumarate as a probe of cell rupture.
INTRODUCTION
Many biochemical processes in cells occur on the sub-minute timescale, making them notoriously difficult to record in situ. NMR spectroscopy has played a central role in our understanding of the kinetics of biochemical reactions in intact cells, with human erythrocytes (red blood cells; RBCs) being the most extensively studied mammalian cell-type. There are many comprehensive kinetic models of enzymatic pathways that were derived using NMR, [1] [2] [3] [4] but such studies have been constrained by the need to acquire the spectral data over prolonged periods of time, with the metabolic system already in a quasi-steady state. The advent of rapid dissolution dynamic nuclear polarization (RD-DNP) enabled monitoring of metabolic conversions of individual 13 C-labeled compounds on the sub-minute timescale using 13 C-NMR spectroscopy in vivo, 5, 6 in cell suspensions 7 or cell lysates, well before an equilibrated state of metabolite concentrations is established.
Fumarase (fumarate hydratase; EC 4.2.1.2) catalyzes the reversible hydration of fumarate to yield L-malate: (1) where k1 and k-1 signify the apparent rate constants of the forward and reverse reactions, respectively. In the history of enzymology, fumarase occupies a special place due to its membership of the tricarboxylic acid (Krebs) cycle; accordingly, its reaction mechanism has been placed under intense scrutiny. [8] [9] [10] Recently, fumarase has assumed a new significance as a diagnostic enzyme for tumor necrosis. 11 It is released into the interstitium of tumor nodules as the central cells become starved of oxygen and nutrients when their multiplication rate outstrips that of vascularization, or after the cells die from antineoplastic therapy. Since the entry of fumarate into cells is slow (the half-life for transport of 26 mM fumarate into RBCs is 11.1 ± 0.4 min), 12 the enzymatic conversion of hyperpolarized [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]fumarate in tumor-bearing mice, as detected on the sub-minute timescale by using RD-DNP, identifies necrosis in tumors in vivo. 11 Thus, it is possible to detect the response of malignant tissues to chemotherapeutic agents, even before any change in the size of the tumor is apparent. 13 The fumarase reaction is well suited for such diagnostic experiments because it is rapid and does not require any cofactors, which simplifies its monitoring in cell lysates.
A notable feature of fumarase biochemistry is that there is only one copy of the corresponding gene in the human genome, and yet it has two primary intracellular locations; 14, 15 one is expectedly in the mitochondria where the Krebs cycle is known to operate, and another is in the cytoplasm.
The enzymes in the two locations are of exactly the same isoform. This raises a question about the role of the cytoplasmic enzyme; but, importantly for the present work, it helps explain why RBCs, which lack mitochondria, still possess fumarase activity. 16, 17 Based on this background knowledge, we aimed to: (a) re-evaluate the in situ kinetics of fumarase in freshly prepared human RBCs via time courses of 1 H spin-echo NMR spectra, 18 in order to assess the potential for kinetic characterization using RD-DNP; (b) record time courses in the very early stages of the fumarase-catalyzed reaction in hemolysates by using RD-DNP with [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 
RBC preparation
RBCs were obtained by cubital fossa venipuncture from a healthy donor (one of the investigators;
Human Ethics cleared at all sites) and washing in iso-osmotic phosphate-buffered saline (PBS;
286 mOsm kg -1 , pH 7.25). Collected blood was centrifuged (10 min, 3000g, 4˚C) and the supernatant and buffy coat were aspirated and discarded. The process of re-suspension of the cells in PBS, centrifugation and supernatant aspiration was repeated twice. For the 1 H-NMR experiments, the suspensions were bubbled with carbon monoxide for 10 min before the final wash. This was done in order to stabilize hemoglobin inside RBCs in a diamagnetic Fe(II) form (carboxyhemoglobin) for optimal spectral resolution and signal-to-noise ratio (S/N). After the final aspiration of the supernatant, the volume fraction of cells in the sample (hematocrit; Ht) was estimated and used in subsequent calculations; it was typically 80-87%. In experiments with hemolysates, RBC suspensions were subjected to two cycles of freezing in liquid nitrogen and thawing at ~30˚C. The samples were used for NMR measurements on the same day.
NMR spectroscopy
1 H-NMR spectra were recorded at 400.13 MHz on a Bruker (Karlsruhe, Germany) Avance III console with a 9.4 T vertical wide-bore magnet from Oxford Instruments (Oxford, UK), equipped with a 10-mm Bruker broadband (BBO) probe.
2.0 mL of freshly prepared hemolysate was added to a 10-mm NMR tube and thermally preequilibrated at 37˚C inside the spectrometer bore. Then, 1.0-2.0 mL of sodium fumarate solution in PBS (pH 7.2) was injected rapidly via a heat-exchanging system designed to pre-equilibrate the fumarate solution to 37˚C, with subsequent mixing. 21 Monitoring the fumarase reaction by recording sequential NMR spectra was started at the time of the injection. Single-transient 1 H spin-echo NMR spectra 18 were acquired every 5 s over a duration of ~20 min using a 90˚ pulse of 29 µs, spectral width of 4 kHz, 4096 complex points, acquisition time of 1.024 s, and spin-echo delay τ = 291 ms, which corresponded to a total echo duration of 582 ms. In the experiments with the whole RBCs, the spin-echo delay was shortened to 190 ms. 13 C-NMR spectra were recorded on a Bruker Avance II 600 MHz spectrometer (150.9 MHz for 13 C) with a 14.1 T vertical magnet using a 10-mm Bruker broadband probe. 
Data processing and analysis
All NMR spectra were processed using TopSpin 3.5 (Bruker); they were extracted as text files and read into Mathematica 22 programs. The spectra were phase corrected and baseline adjusted prior to analysis; exponential window functions with line broadening factors of 5.0 Hz and 10.0 Hz were used in the processing of 1 H and 13 C spectra, respectively. In some instances, several initial spectra showed inconsistent intensities due to incomplete sample mixing so they were discarded from the analysis.
The following kinetic modeling was based on the reaction time courses (temporal evolution of the fumarate and malate signals), which were processed by measuring the integrals of the corresponding peaks in each of the spectra, and then converting these values into respective concentrations, as described below. to the inequivalent positions C1 and C4, were summed and these integral values were scaled by the same factor as those of fumarate.
The 13 C-NMR RD-DNP data were studied using FmRα analysis to obtain initial estimates of the kinetic and relaxation rate constants. Next, the obtained estimates were used as starting parameter values in an MCMC method for fitting the mathematical representation of the fumarase reaction (see below). The application of a small flip-angle excitation pulse was built into the model to account for losses of signals due to the readout of the magnetizations at each time step. Our implementation of the MCMC algorithm was previously described in detail. 20, 25, 26 . Figure 1 shows a stacked plot of typical 1 H spin-echo NMR spectra obtained upon addition of fumarate to a hemolysate, along with the corresponding spectral assignments. Fumarate injection resulted in the immediate appearance of a singlet at 6.49 ppm, corresponding to the two equivalent hydrogen atoms of fumarate (2H and 3H). Subsequently, the conversion of fumarate into malate was evidenced by the decline of the fumarate signal and appearance of three peaks, corresponding to the three inequivalent hydrogen atoms of malate: 2H (4.27 ppm), 3HR (2.64 ppm) and 3HS (2.33 ppm). The peaks corresponding to 3HR and 3HS had negative intensities due to the 1 H-1 H Jcoupling modulations for the chosen value of the delay τ (291 ms) in the spin-echo experiment.
RESULTS

H NMR of hemolysates
The peak at 1.30 ppm was assigned to 3H of lactate, which is present due to the ongoing glycolytic pathway from endogenous 2,3-biphosphoglycerate (23BPG). No other metabolites were seen in the spectra. 
Modeling of 1 H-NMR time courses
Kinetic modeling of the experimental 1 H spin-echo time courses was based on the steady-state (with respect to the concentration of the enzyme-substrate complex) Michaelis-Menten equations, modified to account for competition between fumarate and malate for the active site in the enzyme. 
In preliminary trial fits, it became evident that we could obtain equally good fits with various Km values below ~1 mM. This implied the Michaelis constants of fumarase for fumarate and malate were in the micromolar range and, as the substrate concentrations used were all above 1 mM, the enzyme was effectively fully saturated at any time point in the reaction. 10 The simultaneous fit of the two time-courses shown in Figure 2 yielded the following estimates of the Michaelis-Menten parameters:
µM; and ! "# = 2.4 ± 0.3, calculated using Equation 6.
H NMR of whole RBCs
Additionally, we investigated the rate of the fumarase reaction upon addition of fumarate to whole intact red blood cells. These experiments were conducted in the same way as the experiments with the hemolysates: 2.0 mL of a fumarate solution was injected into 2.0 mL of RBC suspension. In contrast to the hemolysate experiments, there was no evidence of the appearance of the malate peaks in the initial 10 min after commencing acquisition of the 1 H spin-echo NMR spectra ( Figure   3 ). This was concluded to be because fumarase was initially located only inside the cells, and, since fumarate penetrates the plasma membrane of RBCs very slowly, 12 there was only very limited access of the injected fumarate to fumarase and hence a lack of reaction.
Having demonstrated no fumarase activity in the time course with whole RBCs for ~10 min, we injected 1.0 mL of the surfactant, Triton X-100, into the reaction medium via the same heatexchange system that provided vigorous mixing. After this event, the conversion of fumarate to malate became evident ( Figure 3 ).
In comparison with a typical hemolysate experiment (Figure 1 ), the spectral S/N was much poorer when intact RBCs were present; this was due to endogenous magnetic field gradients that they induce. 29 In order to obtain better S/N in the initial spectra, when samples consisted mostly of whole cells, we used a shorter spin-echo delay (τ = 190 ms). As the cells were being lysed in the presence of the surfactant, the S/N grew significantly. Therefore, for clarity of Figure 3 , the amplitude of the fumarate peak was adjusted to be the same in all shown spectra. Shortening the spin-echo delay τ resulted in an altered pattern of signs of the malate peak intensities (Figure 3) Figure   4 ). As illustrated in Figure 5 , the intensity of the malate resonance reached a maximum at tmax = ~20 s and it was smaller by a factor of ~100 than the starting intensity of the fumarate resonance.
Both resonances had declined into the noise ~120 s after the injection.
C-NMR RD-DNP -FmRα analysis
Initially, time courses of 13 C-NMR RD-DNP spectra were analyzed using our recently developed FmRα analysis. 19 Figure 5 shows the application of this method to the time course of 13 C-NMR signal intensities of fumarate and malate, obtained using the spectra of . This value is in a very good agreement with the value of the initial flux of the reaction calculated by using 1 H-NMR time courses (see above).
C-NMR RD-DNP -MCMC analysis
Using the values of the kinetic and relaxation rate constants obtained via the FmRα analysis as the initial estimates, a more comprehensive kinetic characterization of the reaction was implemented using MCMC fitting of the Michaelis-Menten model to the experimental 13 C-NMR time courses.
The model was based on a set of four coupled linear differential equations that describe the time evolution of the concentrations of the 13 C-labeled reactants involved in the reaction. As described previously, 21,30,31 each molecular species undergoing physical/chemical transformations in the RD-DNP experiments, might be conceptually split into two pools: hyperpolarized (or 'labeled') and non-hyperpolarized, with only the hyperpolarized species contributing to the detectable signal. The relevant kinetic scheme, which forms the basis for formulating the following kinetic equations, is shown in Figure 6 ; it leads to a system of four coupled differential equations: 
where the asterisks denote the hyperpolarized species. The values of T1 apply to fumarate (Fum) and malate (Mal), and the apparent unidirectional rate constants k1 and k-1 characterize the flux in the forward and reverse reactions, as shown in Equation 1. While these equations are the basis of the FmRα analysis, they disregard the Michaelis-Menten nature of the kinetic processes; and it transpired that they did not lead to good fits to the experimental data shown in Figure 7A . Hence, the differential equations were further expanded to account for the effects of product inhibition/competition (see below), which allowed us to obtain a more comprehensive and statistically robust fit of the model to the experimental data.
According to the Michaelis-Menten model, the apparent unidirectional rate constants in Equations 7-10 can be expressed in terms of concentrations of the two competing substrates; however, a subtle point worth noting is that these concentrations must contain the sums of both hyperpolarized and non-hyperpolarized species:
where, as before, the asterisks denote the hyperpolarized species; the maximal velocities J .'K ,-. and 
DISCUSSION
H-NMR time courses
The 1 H-NMR time courses (Figure 2) showed that the rate of the fumarate-to-malate conversion in hemolysates was close to that reported by Simpson et al. 12 In this previous work, the half-life of conversion of 30 mM fumarate (in a hemolysate of Ht = 83%) was ~3 min. A detailed kinetic characterization of RBC fumarase was not the aim of that work; nevertheless, the maximum flux measured in our work (4.6 ± 0.3 mmol (L RBC) -1 min -1 ) corresponded to conversion of 11.5 mM of fumarate in 3 min in a hemolysate of Ht = 83%, while it would have implied conversion of 15 mM fumarate using the previously reported rate. 12 The experimental conditions differed in both projects, especially the freshness of the hemolysates, so a comparison must be made cautiously.
Nevertheless, estimating a reaction rate to within a factor of ~1.5 of the previous work was encouraging for the next series of measurements. Importantly, the rates estimated from the 1 H-NMR experiments indicated that the fumarase reaction in hemolysates was sufficiently rapid to be characterized successfully by the 13 C-NMR RD-DNP experiments, the latter being especially useful for the kinetic characterization of metabolic processes in vivo.
Theoretically, malate can be further converted in RBCs to oxaloacetate, pyruvate and lactate. 12 This pathway occurs via oxidation of malate by malate dehydrogenase (EC 1.1.1.37) and requires significant levels of free NAD + /NADH in the system. However, in hemolysates most of the free NAD + /NADH is destroyed by contact with the NAD(P) + nucleosidase (EC 3.2.2.6) which is located on the cell exterior. 33 Thus, the rate of malate to lactate conversion in hemolysates was reported to be negligible when no external NAD + is added to the sample, 12 and we concluded that the lactate seen in our spectra ( Figure 1 ) was produced via glycolysis from 23BPG.
The equilibrium constant of the fumarase reaction (Keq) was previously shown to be a function of the ionic strength of the medium, temperature, and pH. 8, 34 Bock and Alberty reported Keq = ~4.8
at an ionic strength of 0.50 M, pH 7.3 and 25˚C, while Scott and Powell reported Keq = 3.8 under the same buffer conditions. 34 Our value of Keq = 2.4 is closer to the value of 3.1, reported by Borsook and Schott, 35 while the Michaelis constant of fumarase for fumarate (3.9 ± 0.3 µM) and malate (25.6 ± 1.0 µM) are in agreement with the literature values. 10 
C-NMR RD-DNP time courses
The observed decay of the 13 C-NMR RD-DNP fumarate signal and the concurrent rise-and-fall of that of malate were conveniently suitable for the application of the FmRα analysis. 19 The initial velocity of the reaction, computed using this procedure The Michaelis constants of fumarase are known to be in the micromolar range, 10 but the inherently low sensitivity of the NMR techniques requires the use of substrate concentrations at least in the millimolar range. This meant that the kinetics of the fumarase reaction was virtually zero-order upon the initial injection of fumarate. However, as the product of the reaction (malate) was being accumulated, the reaction was increasingly subjected to product inhibition, according to the ratio of the two Michaelis constants and maximum velocities.
Estimated maximum velocities of the reaction in the forward and reverse direction were found to Therefore, we concluded that variability in the estimates of the kinetic parameters between the 1 H and 13 C-NMR data was not caused by gradients in the sample temperature.
Nevertheless, there were some differences in the chemical composition of the media between the 1 H and 13 C-NMR experiments, which were unavoidable due to the specific requirements for the preparation of the hyperpolarized samples. Specifically, the trityl radical DOTAREM and solvent DMSO were present in the samples for the RD-DNP experiments. Although the final concentrations of these compounds were small, we cannot rule out the possibility of them having an effect on the fumarase reaction. Phosphate, on the other hand, is a known effector of fumarase (activating reagent). After the volume of the sample occupied by the cells was taken into account, activity units in the latter. Thus, the effect of our particular phosphate concentration was deemed to be non-significant (~3-4% variation) and would not fully account for the observed difference in the fumarase activity.
The estimates of T1 values were in good agreement among the two methods used to obtain them: 
Implications for in vivo studies
While our Even though neoplastic formation is not typically associated with hemolysis, there are at least three factors which might mediate the rupture of RBCs in a tumor: autoimmune processes (autoimmune hemolytic anemia), 38 microangiopathic disorders [38] [39] [40] [41] and chemotherapy. 38, 42, 43 The deduction about the contribution of ruptured RBCs to the fumarase reaction in necrotic tissues awaits verification, by making measurements on tumor tissue or cancer-cell suspensions in vitro. The NMR and data-analysis methodologies developed here will be beneficial for these future studies.
Conclusions and future directions
We ~10 min from the start of the reaction, 1.0 mL of Triton X-100 was injected into the medium.
The relevant peak assignments are indicated above the top spectrum. For clarity, every tenth spectrum is shown and the amplitude of the fumarate peak was adjusted to be the same in all shown spectra. 
